Demographic and Behavioral Risk Factors Associated with Reduced Susceptibility of Neisseria gonorrhoeae to First-Line Antimicrobials in South African Men with Gonococcal Urethral Discharge
暂无分享,去创建一个
D. Lewis | R. Kularatne | T. Kufa | L. Gumede | D. V. Maseko
[1] H. Jacquier,et al. Two cases of multidrug-resistant Neisseria gonorrhoeae related to travel in south-eastern Asia, France, June 2019 , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[2] K. Pabbaraju,et al. Genetic Characterization and Enhanced Surveillance of Ceftriaxone-Resistant Neisseria gonorrhoeae Strain, Alberta, Canada, 2018 , 2019, Emerging infectious diseases.
[3] C. Fairley,et al. Trends and Risk Factors for Antimicrobial-Resistant Neisseria gonorrhoeae, Melbourne, Australia, 2007 to 2018 , 2019, Antimicrobial Agents and Chemotherapy.
[4] Shao-Chun Chen,et al. Identification of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain FC428, China , 2019, Emerging infectious diseases.
[5] T. Street,et al. Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018 , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[6] M. Unemo,et al. Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[7] R. Kularatne,et al. Trends in Neisseria gonorrhoeae Antimicrobial Resistance over a Ten-Year Surveillance Period, Johannesburg, South Africa, 2008–2017 , 2018, Antibiotics.
[8] M. Unemo,et al. Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[9] Monica Lahra,et al. Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin. , 2018, The Lancet. Infectious diseases.
[10] W. Demczuk,et al. Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain , 2018, Emerging infectious diseases.
[11] A. Katz. Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017 , 2018, Emerging infectious diseases.
[12] M. Unemo,et al. Neisseria cinerea with High Ceftriaxone MIC Is a Source of Ceftriaxone and Cefixime Resistance-Mediating penA Sequences in Neisseria gonorrhoeae , 2018, Antimicrobial Agents and Chemotherapy.
[13] X. Vallès,et al. Risk factors for antimicrobial-resistant Neisseria gonorrhoeae and characteristics of patients infected with gonorrhea. , 2017, Enfermedades infecciosas y microbiologia clinica.
[14] Prateek Shrivastava,et al. World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics , 2018 .
[15] L. Sánchez-Busó,et al. The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. , 2016, The Journal of antimicrobial chemotherapy.
[16] N. Woodford,et al. Drifting towards ceftriaxone treatment failure in gonorrhoea: risk factor analysis of data from the Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales , 2016, Sexually Transmitted Infections.
[17] M. Unemo,et al. Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea. , 2016, The New England journal of medicine.
[18] K. Workowski,et al. Management of Gonorrhea in Adolescents and Adults in the United States. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] D. Lewis. Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains? , 2015, Sexually Transmitted Infections.
[20] A. Amato-Gauci,et al. Risk Factors for Antimicrobial-Resistant Neisseria gonorrhoeae in Europe , 2014, Sexually transmitted diseases.
[21] M. Unemo,et al. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. , 2013, The Journal of antimicrobial chemotherapy.
[22] Makoto Ohnishi,et al. Ceftriaxone-Resistant Neisseria gonorrhoeae, Japan , 2011, Emerging infectious diseases.
[23] F. Radebe,et al. Etiology and STI/HIV Coinfections Among Patients With Urethral and Vaginal Discharge Syndromes in South Africa , 2010, Sexually transmitted diseases.
[24] H. D. de Vries,et al. Multidrug-resistant Neisseria gonorrhoeae with reduced cefotaxime susceptibility is increasingly common in men who have sex with men, Amsterdam, the Netherlands. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[25] F. Radebe,et al. Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: association with HIV seropositivity , 2008, Sexually Transmitted Infections.